A phase II study of fenretinide in patients with hormone refractory prostate cancer: a trial of the Cancer Therapeutics Research Group

Author： Moore M.   Stockler M.   Lim R.   Mok T.   Millward M.   Boyer M.  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.66, Iss.5, 2010-10, pp. : 845-850

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Phase II Trial of Oral 1,25-Dihydroxyvitamin D (Calcitriol) in Hormone Refractory Prostate Cancer

By Osborn J.L.   Schwartz G.G.   Smith D.C.   Bahnson R.   Day R.   Trump D.L.  

Urologic Oncology: Seminars and Original Investigations, Vol. 1, Iss. 5, 1995-09 ,pp. : 195-198

Elsevier

Access to resources Recommend Favorite

Phase II Study of Estramustine and Vinorelbine in Hormone-Refractory Prostate Carcinoma Patients

By Carles Joan   Domenech Montserrat   Gelabert-Mas Antonio   Nogue Miquel   Tabernero Josep M.   Arcusa Angeles   Guasch Inmaculada   Miguel Ana   Ballesteros Juan J.   Fabregat Xavier  

Acta Oncologica, Vol. 37, Iss. 2, 1998-05 ,pp. : 187-191

Informa Healthcare

Access to resources Recommend Favorite

Irofulven as first line therapy in recurrent or metastatic gastric cancer: a phase II multicenter study by the Cancer Therapeutics Research Group (CTRG)

By Yeo W.   Boyer M.   Chung H.   Ong S.   Lim R.   Zee Benny   Ma B.   Lam K.   Mo F.   Ng E.   Ho R.   Clarke S.   Roh J.   Beale P.   Rha S.   Jeung H.   Soo R.   Goh B.   Chan A.  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 3, 2007-03 ,pp. : 295-300

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of carboplatin in patients with advanced or recurrent endometrial carcinoma. A trial of the EORTC Gynaecological Cancer Group

By van Wijk F.H.   Lhomme C.   Bolis G.   Scotto di Palumbo V.   Tumolo S.   Nooij M.   de Oliveira C.F.   Vermorken J.B.  

European Journal of Cancer, Vol. 39, Iss. 1, 2003-01 ,pp. : 78-85

Elsevier

Access to resources Recommend Favorite

Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group

By Aapro M.S.   van Wijk F.H.   van der Burg M.E.L.   ten Bokkel Huinink W.   Vergote I.   Guastalla J.P.   Rosso R.   Kobierska A.   Beex L.V.A.   Namer M.   Splinter T.E.W.   Vermorken J.B.  

European Journal of Cancer, Vol. 39, Iss. 8, 2003-05 ,pp. : 1141-1143

Elsevier

Access to resources Recommend Favorite